Nanollose Limited (NC6.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -1.14 Million AUD | 5.27% |
| 2023 | -1.15 Million AUD | 11.99% |
| 2022 | -1.51 Million AUD | -46.21% |
| 2021 | -873.73 Thousand AUD | 32.91% |
| 2020 | -1.31 Million AUD | 22.48% |
| 2019 | -2.01 Million AUD | -18.93% |
| 2018 | -1.77 Million AUD | -131.68% |
| 2017 | -817.43 Thousand AUD | -8586.93% |
| 2016 | -9409.00 AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | 7.13% |
| 2024 Q2 | -786.67 Thousand AUD | -42.17% |
| 2024 Q4 | -641.51 Thousand AUD | -26.68% |
| 2023 Q2 | -803.75 Thousand AUD | 0.0% |
| 2023 Q4 | -703.8 Thousand AUD | 0.0% |
| 2023 FY | - AUD | 11.99% |
| 2022 Q2 | -942.73 Thousand AUD | 0.0% |
| 2022 FY | - AUD | -46.21% |
| 2022 Q4 | -770.11 Thousand AUD | 0.0% |
| 2021 Q4 | -757.71 Thousand AUD | 0.0% |
| 2021 Q2 | -413.8 Thousand AUD | 0.0% |
| 2021 FY | - AUD | 32.91% |
| 2020 Q2 | -1.02 Million AUD | 0.0% |
| 2020 FY | - AUD | 22.48% |
| 2020 Q4 | -719.62 Thousand AUD | 0.0% |
| 2019 FY | - AUD | -18.93% |
| 2019 Q4 | -1.2 Million AUD | 0.0% |
| 2019 Q2 | -1 Million AUD | 0.0% |
| 2018 FY | - AUD | -131.68% |
| 2018 Q4 | -1.04 Million AUD | 0.0% |
| 2018 Q2 | -733.69 Thousand AUD | 0.0% |
| 2017 Q4 | -356.57 Thousand AUD | 0.0% |
| 2017 Q1 | -230.43 Thousand AUD | 0.0% |
| 2017 FY | - AUD | -8586.93% |
| 2017 Q3 | - AUD | 100.0% |
| 2017 Q2 | -460.86 Thousand AUD | -100.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 111.064% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 21.197% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 96.85% |
| Biome Australia Limited | -1.57 Million AUD | 27.268% |
| Patrys Limited | -3.49 Million AUD | 67.129% |
| Orthocell Limited | -11.68 Million AUD | 90.173% |
| Imugene Limited | -147.97 Million AUD | 99.224% |
| Noxopharm Limited | -5.94 Million AUD | 80.693% |
| PYC Therapeutics Limited | -38.11 Million AUD | 96.989% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 89.841% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 84.025% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 85.446% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 88.464% |
| CSL Limited | 4.73 Billion AUD | 100.024% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 87.005% |
| Bio-Gene Technology Limited | -2.97 Million AUD | 61.415% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 102.213% |
| Starpharma Holdings Limited | -12.57 Million AUD | 90.873% |
| Memphasys Limited | -3.3 Million AUD | 65.296% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -59.333% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | 36.096% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 74.825% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 91.753% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | 59.267% |
| Race Oncology Limited | -14.2 Million AUD | 91.918% |
| Nyrada Inc. | -4.59 Million AUD | 75.025% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 104.998% |
| Dimerix Limited | -24.95 Million AUD | 95.401% |
| PharmAust Limited | -9.45 Million AUD | 87.855% |
| Immutep Limited | -42.87 Million AUD | 97.323% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 97.429% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 94.135% |
| BTC Health Limited | 1.05 Million AUD | 208.776% |
| Acrux Limited | -7.93 Million AUD | 85.526% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 100.576% |
| Biotron Limited | -5.04 Million AUD | 77.224% |
| Tissue Repair Ltd | -5.77 Million AUD | 80.123% |
| AdAlta Limited | -5.3 Million AUD | 78.353% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 97.47% |
| Hexima Limited | -995.54 Thousand AUD | -15.304% |
| AnteoTech Limited | -11.57 Million AUD | 90.079% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 98.221% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 94.624% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 64.598% |
| Actinogen Medical Limited | -12.92 Million AUD | 91.116% |
| Immuron Limited | -6.19 Million AUD | 81.463% |
| Argenica Therapeutics Limited | -1.89 Million AUD | 39.507% |